Int’l Pricing Index Rule Would Take Savings From Drug Pricing Bills

By John Wilkerson / September 17, 2019 at 2:48 PM
If CMS formally proposes an International Pricing Index rule, it would reduce the savings that could be claimed in drug pricing legislation, making it more difficult for Congress to pay for capping seniors’ annual drug costs, extending Medicare programs and policies, and instituting other policy priorities in a year-end spending package to which drug pricing legislation is expected to be attached, sources say. The goal of the International Pricing Index is to lower drug prices, which would lower Medicare spending,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.